Pear Therapeutics closes $50mm Series B round
Executive Summary
Pear Therapeutics Inc. (prescription digital therapeutics) closed a $50mm Series B financing round led by Temasek, which joins other new investors Novartis and EDBI, as well as returning backers 5AM Ventures, Arboretum Ventures, Jazz Venture Partners, and the Bridge Builder’s Collaborative.
Deal Industry
- Digital Health
- Medical Devices
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice